These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 38442747)

  • 1. Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system.
    Zhu P; Simon I; Kokalari I; Kohane DS; Rwei AY
    Adv Drug Deliv Rev; 2024 May; 208():115275. PubMed ID: 38442747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery.
    Kooiman K; Roovers S; Langeveld SAG; Kleven RT; Dewitte H; O'Reilly MA; Escoffre JM; Bouakaz A; Verweij MD; Hynynen K; Lentacker I; Stride E; Holland CK
    Ultrasound Med Biol; 2020 Jun; 46(6):1296-1325. PubMed ID: 32165014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbubble Agents: New Directions.
    Stride E; Segers T; Lajoinie G; Cherkaoui S; Bettinger T; Versluis M; Borden M
    Ultrasound Med Biol; 2020 Jun; 46(6):1326-1343. PubMed ID: 32169397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound and microbubble mediated therapeutic delivery: Underlying mechanisms and future outlook.
    Chowdhury SM; Abou-Elkacem L; Lee T; Dahl J; Lutz AM
    J Control Release; 2020 Oct; 326():75-90. PubMed ID: 32554041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opening doors with ultrasound and microbubbles: Beating biological barriers to promote drug delivery.
    Deprez J; Lajoinie G; Engelen Y; De Smedt SC; Lentacker I
    Adv Drug Deliv Rev; 2021 May; 172():9-36. PubMed ID: 33705877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbubbles as ultrasound contrast agents and in targeted drug delivery.
    Sheffield P; Trehan A; Boyd B; Wong OL
    Crit Rev Biomed Eng; 2008; 36(4):225-55. PubMed ID: 19961426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications.
    Tzu-Yin W; Wilson KE; Machtaler S; Willmann JK
    Curr Pharm Biotechnol; 2013; 14(8):743-52. PubMed ID: 24372231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.
    Sun T; Zhang Y; Power C; Alexander PM; Sutton JT; Aryal M; Vykhodtseva N; Miller EL; McDannold NJ
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10281-E10290. PubMed ID: 29133392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Vascular Permeability by Microbubbles and Ultrasound in Drug Delivery.
    Omata D; Munakata L; Maruyama K; Suzuki R
    Biol Pharm Bull; 2021; 44(10):1391-1398. PubMed ID: 34602547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research.
    Bouakaz A; Michel Escoffre J
    Adv Drug Deliv Rev; 2024 Mar; 206():115199. PubMed ID: 38325561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications.
    Klibanov AL
    Invest Radiol; 2006 Mar; 41(3):354-62. PubMed ID: 16481920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic targeting and ultrasound mediated drug delivery: benefits, limitations and combination.
    Owen J; Pankhurst Q; Stride E
    Int J Hyperthermia; 2012; 28(4):362-73. PubMed ID: 22621737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound microbubble contrast agents: application to therapy for peripheral vascular disease.
    Hu YZ; Zhu JA; Jiang YG; Hu B
    Adv Ther; 2009 Apr; 26(4):425-34. PubMed ID: 19381521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-mediated strategies in opening brain barriers for drug brain delivery.
    Zhao YZ; Lu CT; Li XK; Cai J
    Expert Opin Drug Deliv; 2013 Jul; 10(7):987-1001. PubMed ID: 23550691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound microbubble contrast agents for diagnostic and therapeutic applications: current status and future design.
    Kang ST; Yeh CK
    Chang Gung Med J; 2012; 35(2):125-39. PubMed ID: 22537927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonic technologies in imaging and drug delivery.
    Ho YJ; Huang CC; Fan CH; Liu HL; Yeh CK
    Cell Mol Life Sci; 2021 Sep; 78(17-18):6119-6141. PubMed ID: 34297166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-Responsive Carriers for Therapeutic Applications.
    Chandan R; Mehta S; Banerjee R
    ACS Biomater Sci Eng; 2020 Sep; 6(9):4731-4747. PubMed ID: 33455210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of Ultrasound Theranostics for Cancer].
    Suzuki R; Maruyama K
    Yakugaku Zasshi; 2018; 138(7):919-922. PubMed ID: 29962469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Ultrasound Technologies for Diagnosis and Therapy.
    Rix A; Lederle W; Theek B; Lammers T; Moonen C; Schmitz G; Kiessling F
    J Nucl Med; 2018 May; 59(5):740-746. PubMed ID: 29496981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular therapeutic uses of targeted ultrasound contrast agents.
    Laing ST; McPherson DD
    Cardiovasc Res; 2009 Sep; 83(4):626-35. PubMed ID: 19581314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.